POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Clinical trials for POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE) explained in plain language.
Never miss a new study
Get alerted when new POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE) trials appear
Sign up with your email to follow new studies for POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New program aims to keep patients with opioid and meth use on track after hospital discharge
Disease control OngoingThis study tests a program called MIAPP that combines a patient navigator, a smartphone app, and small rewards to help people who use both opioids and methamphetamine stay connected to addiction treatment after leaving the hospital. About 40 adults who started buprenorphine while…
Matched conditions: POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Phase: NA • Sponsor: University of Washington • Aim: Disease control
Last updated May 22, 2026 14:04 UTC
-
Can a Parent-Peer team help young adults beat polysubstance use? a new study aims to find out
Knowledge-focused OngoingThis study tests a program called Launch for young adults aged 18-26 who misuse multiple drugs. It pairs them with a peer recovery coach and helps a supportive parent use a reward-based method at home. The goal is to see if the program is practical and well-liked, setting the sta…
Matched conditions: POLYSUBSTANCE DRUG USE (INDISCRIMINATE DRUG USE)
Phase: NA • Sponsor: Chestnut Health Systems • Aim: Knowledge-focused
Last updated May 26, 2026 08:10 UTC